Devin Miles, ND

Abstract

This article reviews the clinical evidence supporting curcumin’s role in inflammation, joint health, and oxidative stress, including comparisons with conventional therapies such as NSAIDs. It also examines the challenges of curcumin bioavailability and evaluates commonly used formulation strategies—including piperine, turmerones, and phytosomes—to guide evidence-based clinical use.

Introduction

Turmeric (Curcuma longa) and curcumin supplement sales exploded in the early 2000’s due to its safety, positive clinical outcomes, and extensive positive research.  Curcumin earned the respect of clinicians because of evidence-based research regarding inflammation and pain reduction. 

The root of turmeric is a traditional botanical that has over 400 published clinical studies related to its ability to support a healthy inflammatory response, immune system function, and antioxidant activity. Curcumin, the primary bioactive compound extracted from turmeric, is part of the main group of active compounds found in turmeric, consisting primarily of curcumin, demethoxycurcumin, and bisdemethoxycurcumin.  

Curcumin has been shown in preclinical studies to help maintain the integrity of connective tissue, support joint comfort, and protect cells from oxidative stress. Laboratory and animal research suggest that curcumin influences multiple pathways related to immune balance and helps maintain a normal response to occasional physiological stress.1

In joint and connective tissue support, curcumin has been shown in experimental models to help preserve cartilage structure, reduce the breakdown of the extracellular matrix, and maintain healthy cytokine balance. By modulating normal inflammatory pathways, curcumin may help promote joint mobility and comfort during normal aging and everyday activities. Its antioxidant properties further contribute to protecting tissues from free radical damage.2

A randomized controlled trial (RCT) was conducted where 80 patients with osteoarthritis were divided into two groups.  One group received curcuminoids 30 mg, three times per day, and the other group received the NSAID drug diclofenac 25mg, three times per day.  There was no significant difference in COX activity within the synovial between the two groups.3

A double blind RCT was conducted where 44 participants were randomized to take diclofenac 75mg/d with placebo and 44 other participants were randomized to take the same dose of diclofenac with curcumin 1000mg/d for 3 months.  The group who also took curcumin showed overall reduced osteoarthritic pain and better function in daily living compared to the group who took diclofenac with placebo.4

In another study, 367 participants with primary knee osteoarthritis were randomized into two groups, with one group taking ibuprofen 1200mg/day and the other taking curcumin extract 1500mg/day for 4 weeks.  The pain reduction from curcumin was deemed noninferior to that of ibuprofen.  There was no difference in the number of patients who experienced adverse events between the two groups; however the number of abdominal pain/discomfort events was significantly greater in the ibuprofen group.5

A similar study was done where 107 patients with primary knee osteoarthritis were randomized either to a group taking ibuprofen 800mg per day or curcumin extract 2g per day for 6 weeks.  There were no significant differences noted between the groups regarding the outcomes of improved pain on level walking and time-assessed knee function for a 100-m walk, and no significant difference in adverse events.6

Turmerones

Turmerones are aromatic compounds found in turmeric essential oil, alongside curcumin and other bioactive constituents with similar activities. Preclinical research suggests that turmerones may help support healthy immune function, maintain normal inflammatory responses, and promote overall cellular health. Turmerones have also been studied for their potential to support cognitive health and a balanced mood by influencing certain signaling pathways in the brain.2

Turmerones have shown immunostimulant activity within human peripheral blood mononuclear cells. Aromatic and α- turmerones have exhibited antiproliferative activities in human hepatoma and breast cancer cells. The presence of α- and aromatic turmerones has been demonstrated to increase the amount of curcumin transported into human intestinal epithelial Caco-2 cells (cells used in research as models for intestinal absorption), thereby enhancing absorption. Turmerone presence has also been shown to be correlated with increased amounts of turmeric reaching the insides of cells.7 

Turmerones have been implicated in neurogenesis. Alpha-turmerone has been shown to stimulate neural stem cell proliferation and differentiation.8  Turmerones help to promote microglial shift toward an anti-inflammatory state,9 and are distinct from curcumins, which have a greater focus on affecting NF-κB.10-12  Thus, turmerones have mechanistic relevance in the settings of multiple sclerosis (MS),13 post-inflammatory brain injury,14 neurodegenerative diseases, as well as mood disorders that involve neuroinflammation.15

Turmerones reduce inflammation by inhibiting the key markers of TNF-α, IL-1β, and iNOS. They exhibit less COX-inhibition than COX-2 inhibiting medications, and thus lead to less gastrointestinal side effects.16-17

Human and animal studies have shown generally good tolerability to turmerones, with no hepatotoxicity or hematological abnormalities at supplemental doses.18-19 In fact, an animal model using hot water extracts of curcumin that contained turmerones showed a decrease in non-alcoholic hepatic steatosis and oxidative stress enzymes.20

Human studies have widely ranged in dosages of whole turmeric, including 40 mg-8000 mg/day.21 Turmerone percentages within turmeric can vary widely, ranging approximately from 6-50%.22

Curcumin supplements are considered very safe, with human studies showing that oral doses up to 12 grams per day are generally well tolerated.2 

Overcoming Curcumin’s Bioavailability Challenges

Despite the safety and extensive research interest, curcumin has a major limitation: very poor oral bioavailability.1,3 It is necessary to take high doses because after oral ingestion, only small amounts of curcumin appear in the bloodstream. This is thought to be due to:

• Poor water solubility
• Limited intestinal absorption
• Rapid metabolism in the intestinal wall and liver
• Possible efflux back into the gut lumen by transport proteins1,3,4

Because of this, there has been a race to develop a more bioavailable formulation. Many popular commercially-available curcumin formulations have been developed to try to improve absorption, including phytosome-complex liposomes, nanoparticles, and combinations with absorption enhancers such as black pepper and turmerones.5, 6, 23-25 This has become the primary advertising focus for curcumin supplement brands. 

One strategy for optimizing curcumin absorption is black pepper. It contains the compound piperine, which has been shown to significantly increase circulating levels of curcumin active compounds in humans.26 Turmerones, naturally occurring turmeric essential oils with anti-inflammatory activity, have also been shown to enhance intestinal transport of curcumin, resulting in better absorption.27 Lecithin acts as an emulsifier and forms a phytosome complex with turmeric, also increasing its absorption.28 

One ingredient company has heavily marketed their popular “phytosome” formula as being superior, which combines lecithin + curcumin. However, other delivery systems can be equally effective while delivering higher levels of certain active compounds.

Comparing Two Bioavailable Formulas

An in vitro study was conducted to compare the curcumin phytosome ingredient to a formula which combines turmerones derived from supercritical CO2 extraction, black pepper, and curcumin, to determine if there was a significant difference in bioavailability. 

This study did not capture real-world factors such as bile acids, microbiota, or systemic metabolism.29 Yet, this study did demonstrate that formulation strategies such as lecithin-curcumin phytosome and piperine/turmerone combinations may influence absorption-related processes, and that there was no major difference in net intestinal transport between the two tested formulas under controlled laboratory conditions.28 Thus, it can be concluded that the turmerone–black pepper formula demonstrated equal bioavailability to the popular phytosome ingredient.

Curcumin bioavailability remains a complex and often misunderstood topic for both clinicians and patients. While many formulations are marketed as uniquely superior, variations in study design, experimental models, and outcome measures make direct comparisons difficult. The available research suggests that multiple formulation strategies may enhance curcumin absorption through different mechanisms, rather than one approach clearly outperforming all others. Greater transparency from supplement companies regarding formulation design, study limitations, and dosing equivalence is essential so clinicians can make informed recommendations and select products that are both evidence-based and clinically appropriate for individual patients.

Dr. Devin Miles, ND provides integrative approaches to cardiovascular health, kidney function, autoimmunity, hormone balance, and prevention. She has been a guest speaker for multiple podcasts, radio shows, and health fairs. She is a medical writer and two-time author of the following books: Natural Approaches to High Blood Pressure and Low Kidney Function and Before You Choose Surgery: Learn from a Doctor’s Story as a Patient Who Underwent Surgery and the Two-year Experience Afterwards. She is the owner of ‘It’s Time Natural Health’ and offers virtual consultations.

References

1. Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The Essential Medicinal Chemistry of Curcumin. J Med Chem. 2017 Mar 9;60(5):1620-1637. doi: 10.1021/acs.jmedchem.6b00975.  https://pubmed.ncbi.nlm.nih.gov/28074653/ 
2. Lao CD, Ruffin MT 4th, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006 Mar 17;6:10. doi: 10.1186/1472-6882-6-10. https://pubmed.ncbi.nlm.nih.gov/16545122/ 
3. Kertia N, Asdie AH, Rochmah W, Marsetyawan. Ability of curcuminoid compared to diclofenac sodium in reducing the secretion of cycloxygenase-2 enzyme by synovial fluid’s monocytes of patients with osteoarthritis. Acta Med Indones. 2012;44(2):105–13. https://pubmed.ncbi.nlm.nih.gov/22745140/ 
4. Pinsornsak P, Niempoog S. The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thai. 2012;95 Suppl 1:S51–8. https://pubmed.ncbi.nlm.nih.gov/23964444/ 
5. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014;9:451–8. doi: 10.2147/CIA.S58535. https://pubmed.ncbi.nlm.nih.gov/24672232/ 
6. Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P, et al. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. J Altern Complement Med. 2009;15(8):891–7. doi: 10.1089/acm.2008.0186. https://pubmed.ncbi.nlm.nih.gov/19678780/ 
7. Yue GG, Cheng SW, Yu H, et al. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J Med Food. 2012 Mar;15(3):242-52. doi: 10.1089/jmf.2011.1845. https://pmc.ncbi.nlm.nih.gov/articles/PMC3282471/
8. Hucklenbroich J, Klein R, Neumaier B, et al. Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo. Stem Cell Res Ther. 2014 Sep 26;5(4):100. doi: 10.1186/scrt500. https://pubmed.ncbi.nlm.nih.gov/25928248/ 
9. Park SY, Jin ML, Kim YH, et al. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-κB, JNK, and p38 MAPK signaling pathways in amyloid β-stimulated microglia. Int Immunopharmacol. 2012 Sep;14(1):13-20. doi: 10.1016/j.intimp.2012.06.003. https://pubmed.ncbi.nlm.nih.gov/22728094/  
10. Christian Jobin, Cynthia A Bradham, Maria Pia Russo, et al. Curcumin Blocks Cytokine-Mediated NF-κB Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-κB Kinase Activity. The Journal of Immunology, Volume 163, Issue 6, September 1999, Pages 3474–3483, https://doi.org/10.4049/jimmunol.163.6.3474 https://academic.oup.com/jimmunol/article-abstract/163/6/3474/8040797?    
11. Kim JH, Gupta SC, Park B, et al. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol Nutr Food Res. 2012 Mar;56(3):454-65. doi: 10.1002/mnfr.201100270. https://pubmed.ncbi.nlm.nih.gov/22147524/
12. Park SY, Jin ML, Kim YH, et al. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-κB, JNK, and p38 MAPK signaling pathways in amyloid β-stimulated microglia. Int Immunopharmacol. 2012 Sep;14(1):13-20. doi: 10.1016/j.intimp.2012.06.003. https://pubmed.ncbi.nlm.nih.gov/22728094/ 
13. Govindarajan V, de Rivero Vaccari JP, Keane RW. Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets. J Neuroinflammation. 2020 Sep 2;17(1):260. doi: 10.1186/s12974-020-01944-9. https://pmc.ncbi.nlm.nih.gov/articles/PMC7469327/ 
14. Zhao K, Zhang Y, Yang S. Neuroinflammation and stress-induced pathophysiology in major depressive disorder: mechanisms and therapeutic implications. Front Cell Neurosci. 2025 Apr 23;19:1538026. doi: 10.3389/fncel.2025.1538026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12055817/ 
15. Zhao K, Zhang Y, Yang S, et al. Neuroinflammation and stress-induced pathophysiology in major depressive disorder: mechanisms and therapeutic implications. Front Cell Neurosci. 2025 Apr 23;19:1538026. doi: 10.3389/fncel.2025.1538026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12055817/ 
16. Lee SK, Hong CH, Huh SK, et al. Suppressive effect of natural sesquiterpenoids on inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) activity in mouse macrophage cells. J Environ Pathol Toxicol Oncol. 2002;21(2):141-8.  https://pubmed.ncbi.nlm.nih.gov/12086400/ 
17. Campos C, de Gregorio R, García-Nieto R. Regulation of cyclooxygenase activity by metamizol. Eur J Pharmacol. 1999 Aug 13;378(3):339-47. doi: 10.1016/s0014-2999(99)00477-x. https://pubmed.ncbi.nlm.nih.gov/10493111/ 
18. Joshi J, Ghaisas S, Vaidya A, Vaidya R, Kamat DV, Bhagwat AN, Bhide S. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J Assoc Physicians India. 2003 Nov;51:1055-60. https://pubmed.ncbi.nlm.nih.gov/15260388/ 
19. Liju VB, Jeena K, Kuttan R. Acute and subchronic toxicity as well as mutagenic evaluation of essential oil from turmeric (Curcuma longa L). Food Chem Toxicol. 2013 Mar;53:52-61. doi: 10.1016/j.fct.2012.11.027. https://pubmed.ncbi.nlm.nih.gov/23201370/ 
20. Uchio R, Murosaki S, Ichikawa H. Hot water extract of turmeric (Curcuma longa) prevents non-alcoholic steatohepatitis in mice by inhibiting hepatic oxidative stress and inflammation. J Nutr Sci. 2018 Dec 27;7:e36. doi: 10.1017/jns.2018.27. https://pmc.ncbi.nlm.nih.gov/articles/PMC6313422/ 
21. Kunnumakkara AB, Hegde M, Parama D, et al. Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials. ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. https://pmc.ncbi.nlm.nih.gov/articles/PMC10111629/  
22. Singh G, Kapoor IP, Singh P, et al. Comparative study of chemical composition and antioxidant activity of fresh and dry rhizomes of turmeric (Curcuma longa Linn.). Food Chem Toxicol. 2010 Apr;48(4):1026-31. doi: 10.1016/j.fct.2010.01.015. https://pubmed.ncbi.nlm.nih.gov/20096323/
23. Bhattacharya S. Phytosomes: the new technology for enhancement of bioavailability of botanicals and nutraceuticals. Int J Health Res. 2009;2:225–32.
24. More Minakshi S, Shende Mulchand A, Kolhe Deul B, Jaiswal Nayna M. Herbosomes: herbo-phospholipid complex: an approach for absorption enhancement. Int J Biol Pharm Res. 2012;3:946–55.
25. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007 Feb 7;330(1-2):155-63. doi: 10.1016/j.ijpharm.2006.09.025. https://pubmed.ncbi.nlm.nih.gov/17112692/ 
26. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May;64(4):353-6. doi: 10.1055/s-2006-957450. https://pubmed.ncbi.nlm.nih.gov/9619120/ 
27. Yue GG, Cheng SW, Yu H, Xu ZS, Lee JK, Hon PM, Lee MY, Kennelly EJ, Deng G, Yeung SK, Cassileth BR, Fung KP, Leung PC, Lau CB. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J Med Food. 2012 Mar;15(3):242-52. doi: 10.1089/jmf.2011.1845. 
28. McLellan A. J Restorative Medicine. 2018 https://restorativemedicine.org/journal/comparison-curcumin-caco-2-human-intestinal-permeability/ 
29. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5. doi: 10.1016/0006-291x(91)91647-u. https://pubmed.ncbi.nlm.nih.gov/1673839/